STE Quote, Financials, Valuation and Earnings

Edwards Lifesciences has a net margin of 9.84% compared to Steris PLC's net margin of 25.34%. Steris PLC's return on equity of 9.5% beat Edwards Lifesciences's return on equity of 46.91%.

Steris PLC has a consensus price target of $263.10, signalling upside risk potential of 7.3%. On the other hand Edwards Lifesciences has an analysts' consensus of $80.97 which suggests that it could grow by 3.51%. Given that Steris PLC has higher upside potential than Edwards Lifesciences, analysts believe Steris PLC is more attractive than Edwards Lifesciences.

Steris PLC has a beta of 0.956, which suggesting that the stock is 4.397% less volatile than S&P 500. In comparison Edwards Lifesciences has a beta of 1.124, suggesting its more volatile than the S&P 500 by 12.434%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.91%. Edwards Lifesciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 35.77% of its earnings as a dividend. Edwards Lifesciences pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.5B, which are larger than Edwards Lifesciences quarterly revenues of $1.4B. Steris PLC's net income of $145.7M is lower than Edwards Lifesciences's net income of $358M. Notably, Steris PLC's price-to-earnings ratio is 39.55x while Edwards Lifesciences's PE ratio is 11.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.45x versus 8.41x for Edwards Lifesciences. Usually stocks with elevated PS ratios are considered overvalued.

Intuitive Surgical has a net margin of 9.84% compared to Steris PLC's net margin of 30.99%. Steris PLC's return on equity of 9.5% beat Intuitive Surgical's return on equity of 15.82%.

Steris PLC has a consensus price target of $263.10, signalling upside risk potential of 7.3%. On the other hand Intuitive Surgical has an analysts' consensus of $575.78 which suggests that it could grow by 4.24%. Given that Steris PLC has higher upside potential than Intuitive Surgical, analysts believe Steris PLC is more attractive than Intuitive Surgical.

Steris PLC has a beta of 0.956, which suggesting that the stock is 4.397% less volatile than S&P 500. In comparison Intuitive Surgical has a beta of 1.697, suggesting its more volatile than the S&P 500 by 69.708%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.91%. Intuitive Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 35.77% of its earnings as a dividend. Intuitive Surgical pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.5B, which are smaller than Intuitive Surgical quarterly revenues of $2.3B. Steris PLC's net income of $145.7M is lower than Intuitive Surgical's net income of $698.4M. Notably, Steris PLC's price-to-earnings ratio is 39.55x while Intuitive Surgical's PE ratio is 80.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.45x versus 23.01x for Intuitive Surgical. Usually stocks with elevated PS ratios are considered overvalued.

Nutriband has a net margin of 9.84% compared to Steris PLC's net margin of -211%. Steris PLC's return on equity of 9.5% beat Nutriband's return on equity of -69.58%.

Steris PLC has a consensus price target of $263.10, signalling upside risk potential of 7.3%. On the other hand Nutriband has an analysts' consensus of $13.00 which suggests that it could grow by 100%. Given that Nutriband has higher upside potential than Steris PLC, analysts believe Nutriband is more attractive than Steris PLC.

Steris PLC has a beta of 0.956, which suggesting that the stock is 4.397% less volatile than S&P 500. In comparison Nutriband has a beta of 1.185, suggesting its more volatile than the S&P 500 by 18.545%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.91%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 35.77% of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.5B, which are larger than Nutriband quarterly revenues of $645.8K. Steris PLC's net income of $145.7M is higher than Nutriband's net income of -$1.4M. Notably, Steris PLC's price-to-earnings ratio is 39.55x while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.45x versus 32.23x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.

Zimmer Biomet Holdings has a net margin of 9.84% compared to Steris PLC's net margin of 9.53%. Steris PLC's return on equity of 9.5% beat Zimmer Biomet Holdings's return on equity of 7.29%.

Steris PLC has a consensus price target of $263.10, signalling upside risk potential of 7.3%. On the other hand Zimmer Biomet Holdings has an analysts' consensus of $108.62 which suggests that it could grow by 17.85%. Given that Zimmer Biomet Holdings has higher upside potential than Steris PLC, analysts believe Zimmer Biomet Holdings is more attractive than Steris PLC.

Steris PLC has a beta of 0.956, which suggesting that the stock is 4.397% less volatile than S&P 500. In comparison Zimmer Biomet Holdings has a beta of 0.780, suggesting its less volatile than the S&P 500 by 21.988%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.91%. Zimmer Biomet Holdings offers a yield of 1.04% to investors and pays a quarterly dividend of $0.24 per share. Steris PLC pays 35.77% of its earnings as a dividend. Zimmer Biomet Holdings pays out 21.69% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.5B, which are smaller than Zimmer Biomet Holdings quarterly revenues of $1.9B. Steris PLC's net income of $145.7M is lower than Zimmer Biomet Holdings's net income of $182M. Notably, Steris PLC's price-to-earnings ratio is 39.55x while Zimmer Biomet Holdings's PE ratio is 20.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.45x versus 2.42x for Zimmer Biomet Holdings. Usually stocks with elevated PS ratios are considered overvalued.